BRCA1 R71K missense mutation contributes to cancer predisposition by increasing alternative transcript levels Journal Article


Authors: Zhang, L.; Chen, L.; Bacares, R.; Ruggeri, J. M.; Somar, J.; Kemel, Y.; Stadler, Z. K.; Offit, K.
Article Title: BRCA1 R71K missense mutation contributes to cancer predisposition by increasing alternative transcript levels
Abstract: Mutation screening of the breast and ovarian cancer predisposition genes BRCA1 and BRCA2 is becoming an increasingly important part of clinical practice. Classification of rare non-truncating sequence variants in the BRCA1 and BRCA2 genes is problematic because it is not known whether these subtle changes alter function sufficiently to predispose cells to cancer development. The BRCA1 331G > A substitution mutation, which occurs at the last nucleotide of exon 5, results in an Arg-to-Lys change at codon 71 (R71K). cDNA analysis indicated that the R71K mutation significantly increases the level of a transcript, characterized by a 22 bp deletion in exon 5, which putatively produces a truncated BRCA1 protein of 63 amino acids. The mutation completely abolishes normal splicing as the mutant allele does not generate any normal transcript. Analysis of a tumor specimen indicates loss of heterozygosity. These results support the conclusion that BRCA1 331G > A (R71K) is a deleterious mutation. © 2011 Springer Science+Business Media, LLC.
Keywords: adult; controlled study; human tissue; middle aged; gene sequence; exon; gene deletion; missense mutation; mutation, missense; case report; neoplasms; cancer susceptibility; genetic predisposition to disease; breast cancer; genetic variability; gene function; genetic transcription; transcription, genetic; mutational analysis; brca1 protein; pedigree; tumor suppressor gene; guanine; alternative splicing; base sequence; amino acid; heterozygosity loss; cancer classification; codon; loss of heterozygosity; genetic predisposition; brca1; lysine; arginine; rna splicing; complementary dna; mutant; nucleotide; adenine; nucleic acid base substitution; r71k
Journal Title: Breast Cancer Research and Treatment
Volume: 130
Issue: 3
ISSN: 0167-6806
Publisher: Springer  
Date Published: 2011-12-01
Start Page: 1051
End Page: 1056
Language: English
DOI: 10.1007/s10549-011-1732-7
PROVIDER: scopus
PUBMED: 21863257
DOI/URL:
Notes: --- - "Export Date: 3 January 2012" - "CODEN: BCTRD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kenneth Offit
    789 Offit
  2. Liying Zhang
    129 Zhang
  3. Zsofia Kinga Stadler
    391 Stadler
  4. Lishi Chen
    18 Chen
  5. Ruben Bacares
    18 Bacares
  6. Joshua Somar
    13 Somar
  7. Yelena Kemel
    103 Kemel